| Kevin Gee, MD | |
|
13133 N Port Washington Rd, Suite 204, Mequon, WI 53097-2419 | |
| (262) 243-2524 | |
| (262) 243-2525 |
| Full Name | Kevin Gee |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 30 Years |
| Location | 13133 N Port Washington Rd, Mequon, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710975289 | NPI | - | NPPES |
| 1710975289 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 41257 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Columbia St Mary's Hospital Milwaukee | Milwaukee, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Columbia St Marys Hospital Milwaukee Inc | 5890604722 | 279 |
| Madison Medical Affiliates Inc | 5991606337 | 84 |
News Archive
New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.
Merck & Co. announced this Monday that they would file for U.S. marketing approval of their experimental insomnia drug suvorexant in 2012.
Dr. Philippe De Wals of Universit' Laval's Department of Social and Preventive Medicine today publishes a study clearly indicating that the addition of folic acid to flours has led to a 46% drop in the incidence of congenital neural tube deformation (mainly anencephaly and spina bifida) in Canada. Such deformations either result in the child's death or in major health problems, including physical and learning disabilities.
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
› Verified 6 days ago
| Entity Name | Columbia St Marys Hospital Milwaukee Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023064482 PECOS PAC ID: 5890604722 Enrollment ID: O20031105000057 |
News Archive
New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.
Merck & Co. announced this Monday that they would file for U.S. marketing approval of their experimental insomnia drug suvorexant in 2012.
Dr. Philippe De Wals of Universit' Laval's Department of Social and Preventive Medicine today publishes a study clearly indicating that the addition of folic acid to flours has led to a 46% drop in the incidence of congenital neural tube deformation (mainly anencephaly and spina bifida) in Canada. Such deformations either result in the child's death or in major health problems, including physical and learning disabilities.
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
› Verified 6 days ago
| Entity Name | Madison Medical Affiliates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588695746 PECOS PAC ID: 5991606337 Enrollment ID: O20040119000018 |
News Archive
New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.
Merck & Co. announced this Monday that they would file for U.S. marketing approval of their experimental insomnia drug suvorexant in 2012.
Dr. Philippe De Wals of Universit' Laval's Department of Social and Preventive Medicine today publishes a study clearly indicating that the addition of folic acid to flours has led to a 46% drop in the incidence of congenital neural tube deformation (mainly anencephaly and spina bifida) in Canada. Such deformations either result in the child's death or in major health problems, including physical and learning disabilities.
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Gee, MD 788 N Jefferson St, Suite 300/attn. Kaaren Butzen, Milwaukee, WI 53202-3718 Ph: (414) 272-8950 | Kevin Gee, MD 13133 N Port Washington Rd, Suite 204, Mequon, WI 53097-2419 Ph: (262) 243-2524 |
News Archive
New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.
Merck & Co. announced this Monday that they would file for U.S. marketing approval of their experimental insomnia drug suvorexant in 2012.
Dr. Philippe De Wals of Universit' Laval's Department of Social and Preventive Medicine today publishes a study clearly indicating that the addition of folic acid to flours has led to a 46% drop in the incidence of congenital neural tube deformation (mainly anencephaly and spina bifida) in Canada. Such deformations either result in the child's death or in major health problems, including physical and learning disabilities.
A new study of mutations in cancer genomes shows how researchers can begin to distinguish the 'driver' mutations that push cells towards cancer from the 'passenger' mutations that are a by-product of cancer cell development. The study also shows that at least one in nine genes can be removed without killing human cells.
› Verified 6 days ago
Christopher Kearns, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 13133 N Port Washington Rd, Suite 204, Mequon, WI 53097 Phone: 262-243-2524 Fax: 262-243-2525 |